In the GLP-1 RA group, 33 participants were subsequently newly diagnosed with heart failure, compared with 15 in the SGLT2i group (RR 0.44 [95% CI 0.23, 0.83] p =0.0092)
Source: Law360 Ineffective Decongestant Cases Consolidated In New York On September 12, 2023, the FDAs Nonprescription Drugs Advisory Committee unanimously determined that oral phenylephrine is ineffective
Moreover, use of dulaglutide in people with T2DM is likely to confer additional renal benefits, and dulaglutide may be used in advanced chronic kidney disease at any eGFR level and without dose adjustment in contrast with most other noninsulin diabetes therapies (134, 135)
In the interim, firms must navigate complex technology transfers, stringent regulations, and supply risks
Combined therapeutics may be used, administered before, after or during administration of the anti-VEGF therapeutic antibody
To find out whether your Aetna plan covers Zepbound, contact Aetna directly, log into the member website to review your plans drug formulary, or use Ros GLP-1 Insurance Checker
